UTMD: Analysis & Opinions

  1. Hospira Downgraded to Strong Sell - Analyst Blog

    January 03, 2013
    On January 2, Zacks Investment Research downgraded Hospira, Inc. (HSP) to a Zacks #5 Rank (Strong Sell). Why the ...
Marketplace
Trading Center